Earnings Ahead

BMY - Bristol-Myers Squibb Co

62.28 -0.51 -0.81

Bristol-Myers Squibb Co

Bristol-Myers Squibb Co

About

Profile

Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm.


Headquarters

New York City, New York, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

BMY



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Bristol-Myers sets below-consensus guidance amid generic competition
  • Bristol-Myers Squibb Company Non-GAAP EPS of $1.75 misses by $0.24, revenue of $11.2B misses by $610M
  • Bristol-Myers Squibb set to continue streak of EPS beats with Q2 results
  • Immatics climbs 8% on $35M investment by Bristol Myers Squibb
  • Catalyst Watch: Earnings blitz, central bank meetings, UPS strike jitters and Barbenheimer
  • Bristol Myers nabs EU endorsement for Opdivo in melanoma
  • J&J becomes latest Big Pharma to sue over Medicare drug pricing
  • HSBC bullish on Roche, Lonza; bearish on Bristol-Myers, GSK, Moderna
  • Eli Lilly, Merck among top pharma picks in Barclays Q2 preview
  • Atrial fibrillation drug market expected to decline as brand therapies go generic
  • Bristol Myers succeeds in Phase 3 trial for Opdivo in bladder cancer
  • Bristol Myers inks licensing pact under Evotec neuroscience deal
  • Bristol gains worldwide license to Prothena Alzheimer's candidate
  • Goldman Sachs sees rays of hope in underperforming health sector
  • Medicare revises guidance on drug price negotiations amid lawsuits
  • Dividend Roundup: General Mills, Mastercard, JPMorgan, Verizon, and more
  • Bristol-Myers Squibb wins EC approval of Camzyos for cardiomyopathy
  • What is behind big pharma's underperformance?
  • Top pharma lobby sues U.S. govt. over Medicare drug pricing negotiations
  • Bristol Myers reportedly sues over new Medicare drug pricing program

Earnings History

Date EPS / Forecast Revenue / Forecast
February 4, 2022 1.83 / 1.8 11.99B / 12.09B
October 27, 2021 2 / 1.92 11.62B / 11.61B Beat!
July 28, 2021 1.93 / 1.89 11.7B / 11.27B Beat!
April 29, 2021 1.74 / 1.81 11.07B / 11.13B
February 4, 2021 1.46 / 1.42 11.07B / 10.73B Beat!
November 5, 2020 1.63 / 1.49 10.54B / 10.32B Beat!
August 6, 2020 1.63 / 1.48 10.13B / 9.99B Beat!
July 23, 2020 - / 1.59 - / 10.4B
May 7, 2020 1.72 / 1.49 10.78B / 10.03B Beat!
February 6, 2020 1.22 / 0.88 7.95B / 7.12B Beat!
October 31, 2019 1.17 / 1.07 6.01B / 5.9B Beat!
July 25, 2019 1.18 / 1.07 6.27B / 6.11B Beat!
April 25, 2019 1.1 / 1.09 5.92B / 5.75B Beat!
January 24, 2019 0.94 / 0.85 5.97B / 5.98B
October 25, 2018 1.09 / 0.91 5.69B / 5.72B
July 26, 2018 1.01 / 0.88 5.7B / 5.44B Beat!
April 26, 2018 0.94 / 0.85 5.19B / 5.25B
February 5, 2018 0.68 / 0.67 5.45B / 5,353M Beat!
October 26, 2017 0.75 / 0.77 5.25B / 5,196M Beat!
July 27, 2017 0.74 / 0.76 5.14B / 5.09B Beat!
April 27, 2017 0.84 / 0.73 4.93B / - Beat!
January 26, 2017 0.84 / 0.73 5.24B / - Beat!
Date Price Open High Low Vol Change ER
Oct 9, 2023 56.61 56.22
57.12
55.7
8.5M -0.09%
Oct 6, 2023 56.66 56.25
56.88
56.17
8.9M 0.43%
Oct 5, 2023 56.42 56.04
56.61
55.83
8.0M -0.55%
Oct 4, 2023 56.73 57.1
57.34
56.31
11.7M -0.86%
Oct 3, 2023 57.22 57.66
58.05
57.12
11.0M -1.09%
 
Oct 2, 2023 57.85 58.01
58.06
57.15
8.9M -0.33%
Sep 29, 2023 58.04 58.18
58.46
57.87
10.9M -0.17%
Sep 28, 2023 58.14 58.01
58.42
57.81
8.3M 0.43%
Sep 27, 2023 57.89 58.58
58.75
57.61
11.4M -1.11%
Sep 26, 2023 58.54 58.87
59.25
58.52
9.4M -1.05%
Sep 25, 2023 59.16 58.84
59.28
58.55
7.0M 0.44%
Sep 22, 2023 58.9 59.33
59.46
58.77
8.2M -0.3%
Sep 21, 2023 59.08 58.56
59.46
58.53
9.6M 0.51%
Sep 20, 2023 58.78 58.8
59.31
58.71
8.7M 0.26%
Sep 19, 2023 58.63 58.56
58.92
58.34
9.0M 0.09%
Sep 18, 2023 58.58 59.04
59.15
58.33
14.6M -0.76%
Sep 15, 2023 59.03 59.44
59.83
58.86
22.4M -0.77%
Sep 14, 2023 59.49 60.14
60.55
59.28
18.1M -0.27%
Sep 13, 2023 59.65 60.25
60.58
59.65
18.2M -0.98%
Sep 12, 2023 60.24 61.01
61.01
59.84
9.7M -0.94%
Sep 11, 2023 60.81 60.75
61.42
60.68
13.2M -0.02%
Sep 8, 2023 60.82 60.16
60.89
60.01
9.5M 1.42%
Sep 7, 2023 59.97 59.87
60.5
59.85
9.3M 0.50%
Sep 6, 2023 59.67 60.3
60.4
59.45
11.5M -1.6%
Sep 5, 2023 60.64 61.89
62
60.59
10.8M -2.23%
Sep 1, 2023 62.02 61.83
62.4
61.83
6.8M 0.60%
Aug 31, 2023 61.65 62.45
62.53
61.65
11.4M -1.17%
Aug 30, 2023 62.38 62.93
63.03
62.2
9.0M -0.75%
Aug 29, 2023 62.85 61.98
63.41
61.98
12.0M 1.96%
Aug 28, 2023 61.64 62.06
62.41
61.38
6.4M -0.71%
Aug 25, 2023 62.08 61.42
62.3
61.25
8.0M 1.31%
Aug 24, 2023 61.28 61.36
62.01
61.22
8.3M -0.45%
Aug 23, 2023 61.56 62.26
62.4
61.41
7.8M -0.48%
Aug 22, 2023 61.86 61.81
62.13
61.6
8.5M -0.08%
Aug 21, 2023 61.91 62.13
62.49
61.9
7.7M -0.24%
Aug 18, 2023 62.06 62.22
62.58
61.87
8.2M -0.14%
Aug 17, 2023 62.15 61.01
62.72
61
17.9M 2%
Aug 16, 2023 60.93 61.34
61.62
60.88
7.9M -1.33%
Aug 15, 2023 61.75 61.53
62.15
61.2
14.4M 0.21%
Aug 14, 2023 61.62 61.35
61.88
61.21
16.5M 0.64%
Aug 11, 2023 61.23 61.53
61.73
61.07
16.8M -0.1%
Aug 10, 2023 61.29 61.09
61.95
60.95
21.1M 1.11%
Aug 9, 2023 60.62 59.8
60.95
59.75
7.7M 0.76%
Aug 8, 2023 60.16 60.69
60.82
59.71
12.5M -0.51%
Aug 7, 2023 60.47 60.51
60.76
60.1
9.8M -0.03%
Aug 4, 2023 60.49 61.08
61.45
60.37
7.6M -1.21%
Aug 3, 2023 61.23 61.46
61.47
60.45
6.7M -0.84%
Aug 2, 2023 61.75 61.17
62.33
61.02
11.9M 0.36%
Aug 1, 2023 61.53 62.32
62.57
61.18
9.2M -1.06%
Jul 31, 2023 62.19 61.35
62.32
61.11
11.7M 1.27%
Jul 28, 2023 61.41 60.8
61.5
60.05
11.6M 1.12%
Jul 27, 2023 60.73 61
62.53
60.38
22.6M -4.23%
Jul 26, 2023 63.41 63.14
63.89
62.92
11.0M -0.56%
Jul 25, 2023 63.77 64.5
64.65
63.75
7.0M -1.48%
Jul 24, 2023 64.73 64.7
65.38
64.7
6.9M 0.08%
Jul 21, 2023 64.68 63.89
64.79
63.76
9.9M 1.43%
Jul 20, 2023 63.77 62.45
64.04
62.37
9.3M 2.76%
Jul 19, 2023 62.06 62.12
62.86
62
8.6M 0.10%
Jul 18, 2023 62 61.94
62.76
61.8
6.4M 0.24%
Jul 17, 2023 61.85 61.99
62.01
61.4
7.5M 0%